Sign in
4

Changes in Ownership

Edesa Biotech, Inc. Filed Acc 0001144204-15-037048

Options or other derivatives

  • Director acquired 25,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

HILL DAVID LOUIS · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2015-06-10 Grant or award : show line 1 in the form Stock Option (Right to Buy) +25,000 25,000 D
Loading xslF345X03/v413043_4.xml…